Text to be removed highlighted in red.
1 New Paragraph; New Hampshire Rx Advantage Program; Insulin Prescriptions for Individuals with Diabetes. Amend RSA 161-L:2 by inserting after paragraph III the following new paragraph:
IV. The program shall include prescription drug assistance for individuals diagnosed with diabetes types 1 and 2. Qualified individuals shall be able to purchase a 30-day supply of insulin for not more than $30 from participating retail pharmacies. The maximum $30 copayment for each 30-day supply of insulin shall apply when an original prescription is dispensed as well as when refills of the prescription are dispensed, including early refills.
2 New Paragraph; New Hampshire Rx Advantage Program; Rulemaking; Diabetes Insulin Assistance. Amend RSA 161-L:6 by inserting after paragraph V the following new paragraph:
VI. Administration of the prescription drug assistance program for individuals with diabetes under RSA 161-L:2, IV, including eligibility criteria, program enrollment, and pharmacy rebate and reimbursement procedures.
3 Effective Date. This act shall take effect January 1, 2024.
Text to be added highlighted in green.
1 New Paragraph; New Hampshire Rx Advantage Program; Insulin Prescriptions for Individuals with Diabetes. Amend RSA 161-L:2 by inserting after paragraph III the following new paragraph:
IV. The program shall include prescription drug assistance for individuals diagnosed with diabetes types 1 and 2. Qualified individuals shall be able to purchase a 30-day supply of insulin for not more than $30 from participating retail pharmacies. The maximum $30 copayment for each 30-day supply of insulin shall apply when an original prescription is dispensed as well as when refills of the prescription are dispensed, including early refills.
2 New Paragraph; New Hampshire Rx Advantage Program; Rulemaking; Diabetes Insulin Assistance. Amend RSA 161-L:6 by inserting after paragraph V the following new paragraph:
VI. Administration of the prescription drug assistance program for individuals with diabetes under RSA 161-L:2, IV, including eligibility criteria, program enrollment, and pharmacy rebate and reimbursement procedures.
3 Effective Date. This act shall take effect January 1, 2024.